By Business Wire, September 18, 2013, 05:00:00 AM EDT
NOKOMIS, Fla.--(BUSINESS WIRE)--
As part of their ongoing efforts to publicize the breakthrough
capabilities of the new Bio-Assembler 3D cell culturing system, Rainbow
Coral Corp. (OTCBB:RBCC) and its joint venture partner Nano3D
Biosciences (n3D) will reanimate last year's highly successful MAD
Scientist Contest to help introduce a new crop of bio-researchers to the
The MAD Scientist Contest is an inventive discovery competition
challenging participants to illustrate how 3-D, levitated cultures
improve data and achieve results impossible with other cell-culturing
systems. Contestants will vie for thousands of dollars in prizes and
grants with experiments exhibiting the in-vivo-like characteristics of
cell cultures created using n3D's magnetic levitation and nanoparticle
The top cash prize for 2012 was awarded to Hamsa Jaganathan, Ph.D., of
the Methodist Hospital Research Institute for her amazing model of a
breast tumor microenvironment, created by co-culturing breast cancer
cells and fibroblasts. In addition to inspiring outside-the-box thinking
among cellular biologists, the MAD Scientist Contest will also serve to
introduce n3D's Bio-Assembler system to the young scientists who will
lead cellular research into the future.
Rainbow BioSciences acquired an equity interest in n3D last year,
positioning the company to participate in the potentially impressive
upside in store for n3D. The MAD Scientist Contest promotion is central
to n3D and RBCC's ongoing efforts to build strong awareness and interest
in the Bio-Assembler among researchers across a broad spectrum of
scientific and research disciplines.
Rainbow Biosciences is dedicated to the marketing and development of new
medical and research technology innovations designed to help capture a
growing share of a booming biotech industry alongside Bristol Myers
Squibb Co. (NYSE:BMY), Biogen Idec Inc. (NASDAQ:BIIB), Abbott
Laboratories (NYSE:ABT) and Amgen Inc. (NASDAQ:AMGN).
For more information on RBCC's partnership with n3D and other biotech
initiatives, please visit www.rainbowbiosciences.com/investors.html.
About Rainbow Biosciences
Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral
Corp. (OTCBB: RBCC). The Company continually seeks out new partnerships
with biotechnology developers to deliver profitable new medical
technologies and innovations. For more information on our
growth-oriented business initiatives, please visit www.RainbowBioSciences.com.
For investment information and performance data on the Company, please
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the Company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the Company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
Source: Rainbow Coral Corp.